Home LiteratureArticle Details
PMID: 10627528 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

The E8E2C protein, a negative regulator of viral transcription and replication, is required for extrachromosomal maintenance of human papillomavirus type 31 in keratinocytes.

Journal of virology ·Vol. 74 ·No. 3 ·2000-02-00 ·Pages 1178-86

Stubenrauch F, Hummel M, Iftner T, Laimins LA

Abstract

The viral E2 protein is a major regulator of papillomavirus DNA replication. An important way to influence viral replication is through modulation of the activity of the E2 protein. This could occur through the action of truncated E2 proteins, called E2 repressors, whose role in the replication cycle of human papillomaviruses (HPVs) has not been determined. In this study, using cell lines that contain episomal copies of the "high-risk" HPV type 31 (HPV31), we have identified viral transcripts with a splice from nucleotide (nt) 1296 to 3295. These transcripts are similar to RNAs from other animal and human papillomaviruses and have the potential to fuse a small open reading frame (E8) to the C terminus of E2, resulting in an E8E2C fusion protein. E8E2C transcripts were present throughout the complete replication cycle of HPV31. A genetic analysis of E8E2C in the context of the HPV31 genome revealed that mutation of the single ATG of the E8 gene, introduction of a stop codon downstream of the ATG, or disruption of the splice donor site at nt 1296 led to a dramatic 30- to 40-fold increase in the transient DNA replication levels in both normal and immortalized human keratinocytes. High-level expression of E8E2C from heterologous vectors was found to inhibit E1-E2-dependent DNA replication of an HPV31 origin of replication construct as well as to interfere with E2's ability to transactivate reporter gene constructs. In addition, HPV31 E8E2C strongly repressed the basal activity of the major viral early promoter P97 independent of E2. E8E2C may therefore exert its negative effect on viral DNA replication through modulating E2's ability to enhance E1-dependent DNA replication as well as by regulating viral gene expression. Surprisingly, HPV31 genomes that were unable to express E8E2C could not be maintained extrachromosomally in human keratinocytes in long-term assays despite high transient DNA replication levels. This suggests that the E8E2C protein may play a role in copy number control as well as in the stable maintenance of HPV episomes.

MeSH Terms
Base Sequence Blotting, Southern Cells, Cultured DNA Replication DNA-Binding Proteins/genetics,metabolism Gene Expression Regulation, Viral Genome, Viral Humans Keratinocytes/virology Molecular Sequence Data Mutation Papillomaviridae/genetics,physiology Plasmids RNA, Messenger/analysis,genetics RNA, Viral/analysis,genetics Recombinant Fusion Proteins/metabolism Repressor Proteins/genetics,metabolism Ribonucleases/metabolism Transcription, Genetic Tumor Cells, Cultured Viral Proteins/genetics,metabolism Virus Replication
Chemicals
DNA-Binding Proteins E2 protein, Human papillomavirus type 31 RNA, Messenger RNA, Viral Recombinant Fusion Proteins Repressor Proteins Viral Proteins Ribonucleases
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Stubenrauch F
Sektion Experimentelle Virologie, Abteilung Medizinische Virologie, Universitätsklinikum Tuebingen, D-72076 Tuebingen, Germany. frank.stubenrauch@med.uni-tuebingen.de
Hummel M
Iftner T
Laimins L A
References (43)
43 references, click to expand
  1. Mechanism of action of the papillomavirus E2 repressor: repression in the absence of DNA binding.
    J Virol. 1992 Jun;66(6):3941-5 PMID: 1316493
  2. The functions of human papillomavirus type 11 E1, E2, and E2C proteins in cell-free DNA replication.
    J Biol Chem. 1995 Nov 10;270(45):27283-91 PMID: 7592989
  3. Biosynthesis of human papillomavirus from a continuous cell line upon epithelial differentiation.
    Science. 1992 Aug 14;257(5072):971-3 PMID: 1323879
  4. Tumorigenic keratinocyte lines requiring anchorage and fibroblast support cultured from human squamous cell carcinomas.
    Cancer Res. 1981 May;41(5):1657-63 PMID: 7214336
  5. A transcriptional repressor encoded by BPV-1 shares a common carboxy-terminal domain with the E2 transactivator.
    Cell. 1987 Jul 3;50(1):69-78 PMID: 3036366
  6. Cis and trans requirements for stable episomal maintenance of the BPV-1 replicator.
    EMBO J. 1996 Jan 2;15(1):1-11 PMID: 8598191
  7. In vitro synthesis of oncogenic human papillomaviruses requires episomal genomes for differentiation-dependent late expression.
    Proc Natl Acad Sci U S A. 1996 Apr 2;93(7):3062-7 PMID: 8610168
  8. A papillomavirus E2 phosphorylation mutant exhibits normal transient replication and transcription but is defective in transformation and plasmid retention.
    J Virol. 1997 May;71(5):3652-65 PMID: 9094639
  9. Induction of human papillomavirus type 18 late gene expression and genomic amplification in organotypic cultures from transfected DNA templates.
    J Virol. 1997 Sep;71(9):7068-72 PMID: 9261437
  10. Synthesis of infectious human papillomavirus type 18 in differentiating epithelium transfected with viral DNA.
    J Virol. 1997 Oct;71(10):7381-6 PMID: 9311816
  11. Differential requirements for conserved E2 binding sites in the life cycle of oncogenic human papillomavirus type 31.
    J Virol. 1998 Feb;72(2):1071-7 PMID: 9445001
  12. Competition for DNA binding sites between the short and long forms of E2 dimers underlies repression in bovine papillomavirus type 1 DNA replication control.
    J Virol. 1998 Mar;72(3):1931-40 PMID: 9499046
  13. Temporal usage of multiple promoters during the life cycle of human papillomavirus type 31b.
    J Virol. 1998 Apr;72(4):2715-22 PMID: 9525589
  14. Human papillomavirus type 31b E1 and E2 transcript expression correlates with vegetative viral genome amplification.
    Virology. 1998 Sep 1;248(2):218-30 PMID: 9721231
  15. Transactivation by the E2 protein of oncogenic human papillomavirus type 31 is not essential for early and late viral functions.
    J Virol. 1998 Oct;72(10):8115-23 PMID: 9733852
  16. DNA replication of human papillomavirus type 31 is modulated by elements of the upstream regulatory region that lie 5' of the minimal origin.
    J Virol. 1999 Mar;73(3):1835-45 PMID: 9971761
  17. Human papillomavirus type 18 E1 protein is translated from polycistronic mRNA by a discontinuous scanning mechanism.
    J Virol. 1999 Apr;73(4):3062-70 PMID: 10074156
  18. Human papillomavirus type 31 oncoproteins E6 and E7 are required for the maintenance of episomes during the viral life cycle in normal human keratinocytes.
    Proc Natl Acad Sci U S A. 1999 Jul 20;96(15):8449-54 PMID: 10411895
  19. The product of the bovine papillomavirus type 1 modulator gene (M) is a phosphoprotein.
    J Virol. 1988 Jul;62(7):2474-82 PMID: 2836626
  20. Regulation of human papillomavirus type 11 enhancer and E6 promoter by activating and repressing proteins from the E2 open reading frame: functional and biochemical studies.
    J Virol. 1988 Aug;62(8):2994-3002 PMID: 2839716
  21. A general method of in vitro preparation and specific mutagenesis of DNA fragments: study of protein and DNA interactions.
    Nucleic Acids Res. 1988 Aug 11;16(15):7351-67 PMID: 3045756
  22. Bovine papilloma virus-transformed cells contain multiple E2 proteins.
    Proc Natl Acad Sci U S A. 1988 Aug;85(16):5864-8 PMID: 2842752
  23. E2 polypeptides encoded by bovine papillomavirus type 1 form dimers through the common carboxyl-terminal domain: transactivation is mediated by the conserved amino-terminal domain.
    Proc Natl Acad Sci U S A. 1989 Jan;86(2):510-4 PMID: 2536165
  24. Bovine papillomavirus type 1 encodes two forms of a transcriptional repressor: structural and functional analysis of new viral cDNAs.
    J Virol. 1989 Apr;63(4):1743-55 PMID: 2538655
  25. Genetic assignment of multiple E2 gene products in bovine papillomavirus-transformed cells.
    J Virol. 1989 Jul;63(7):3151-4 PMID: 2542621
  26. Characterization of rare human papillomavirus type 11 mRNAs coding for regulatory and structural proteins, using the polymerase chain reaction.
    Virology. 1989 Oct;172(2):489-97 PMID: 2552659
  27. Bovine papillomavirus E2 repressor mutant displays a high-copy-number phenotype and enhanced transforming activity.
    J Virol. 1990 Feb;64(2):944-9 PMID: 2153255
  28. Phenotypic analysis of bovine papillomavirus type 1 E2 repressor mutants.
    J Virol. 1990 Feb;64(2):950-6 PMID: 2153256
  29. Detection of novel splicing patterns in a HPV16-containing keratinocyte cell line.
    Virology. 1990 Sep;178(1):254-62 PMID: 2167553
  30. Transient replication of BPV-1 requires two viral polypeptides encoded by the E1 and E2 open reading frames.
    EMBO J. 1991 Feb;10(2):449-57 PMID: 1846806
  31. Amplification of human papillomavirus genomes in vitro is dependent on epithelial differentiation.
    J Virol. 1991 May;65(5):2254-60 PMID: 1850010
  32. An E1M--E2C fusion protein encoded by human papillomavirus type 11 is asequence-specific transcription repressor.
    J Virol. 1991 Jun;65(6):3317-29 PMID: 1851879
  33. The papillomavirus E2 regulatory proteins.
    J Biol Chem. 1991 Oct 5;266(28):18411-4 PMID: 1655748
  34. Bovine papillomavirus with a mutation in the E2 serine 301 phosphorylation site replicates at a high copy number.
    J Virol. 1991 Dec;65(12):6528-34 PMID: 1658358
  35. Human papillomavirus type 33 in a tonsillar carcinoma generates its putative E7 mRNA via two E6* transcript species which are terminated at different early region poly(A) sites.
    J Virol. 1992 May;66(5):3172-8 PMID: 1313922
  36. Differentiation-induced and constitutive transcription of human papillomavirus type 31b in cell lines containing viral episomes.
    J Virol. 1992 Oct;66(10):6070-80 PMID: 1326657
  37. The 23-kilodalton E1 phosphoprotein of bovine papillomavirus type 1 is nonessential for stable plasmid replication in murine C127 cells.
    J Virol. 1993 May;67(5):2932-7 PMID: 8386283
  38. Identification and characterization of novel promoters in the genome of human papillomavirus type 18.
    J Virol. 1993 Jul;67(7):4296-306 PMID: 8389929
  39. Molecular pathogenesis of cancer of the cervix and its causation by specific human papillomavirus types.
    Curr Top Microbiol Immunol. 1994;186:131-56 PMID: 8205839
  40. The role of the E1 and E2 proteins in the replication of human papillomavirus type 31b.
    Virology. 1994 Nov 1;204(2):799-804 PMID: 7941349
  41. Characterization of the human papillomavirus E2 protein: evidence of trans-activation and trans-repression in cervical keratinocytes.
    EMBO J. 1994 Nov 15;13(22):5451-9 PMID: 7957111
  42. Integration of human papillomavirus type 16 into the human genome correlates with a selective growth advantage of cells.
    J Virol. 1995 May;69(5):2989-97 PMID: 7707525
  43. Control of human papillomavirus type 11 origin of replication by the E2 family of transcription regulatory proteins.
    J Virol. 1992 Sep;66(9):5224-31 PMID: 1323690
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
2000-02-00
Pages
1178-86
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC111452
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com